Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Santaballa
R Vera

Showing results (1-10 of 328) with videos related to

Pageof 33
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 18, 2018
Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM)A Santaballa, J De Castro, J Maurel, et al.
Breast (Edinburgh, Scotland)|June 5, 2004
Hepatic resection in breast cancer metastases: should it be considered standard treatment?R Díaz, A Santaballa, B Munárriz, et al.
Talanta|October 1, 1985
CONSEL, a least-squares program for estimating stability constants from polarographic dataJ A Santaballa, C Blanco, F Arce, et al.
The Breast Journal|November 7, 2007
Cost-benefit analysis of a follow-up program in patients with breast cancer: a randomized prospective studyAmparo Oltra, A Santaballa, B Munárriz, et al.
Journal of Photochemistry and Photobiology. B, Biology|May 29, 2002
Reaction pathways and mechanisms of photodegradation of pesticidesH D Burrows, M Canle L, J A Santaballa, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|March 9, 2004
Diethyl 1-(4-fluorophenyl)-3-(2-furyl)-5-oxopyrrolidine-2,2-dicarboxylate and diethyl 1-(3,4-dichlorophenyl)-3-(2-furyl)-5-oxopyrrolidine-2,2-dicarboxylateJayanta Kumar Ray, Pranab Haldar, M Canle L, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
ESHAP is an active regimen for relapsing Hodgkin's diseaseJ Aparicio, A Segura, S Garcerá, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
1-(3-Chloro-4-fluoro-phen-yl)-5-(2-diazo-acet-yl)-4-phenyl-pyrrolidin-2-oneJayanta Kumar Ray, Pranab Haldar, M Canle L, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
Diethyl 1-(4-methyl-phen-yl)-3-phenyl-5-oxopyrrolidine-2,2-dicarboxyl-ateJayanta Kumar Ray, Gopa Barman, M Canle L, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1992
Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistryD R Vera
Pageof 33

Showing results (1-10 of 328) with videos related to

Sort By:
Pageof 33
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 18, 2018
Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM)A Santaballa, J De Castro, J Maurel, et al.
Breast (Edinburgh, Scotland)|June 5, 2004
Hepatic resection in breast cancer metastases: should it be considered standard treatment?R Díaz, A Santaballa, B Munárriz, et al.
Talanta|October 1, 1985
CONSEL, a least-squares program for estimating stability constants from polarographic dataJ A Santaballa, C Blanco, F Arce, et al.
The Breast Journal|November 7, 2007
Cost-benefit analysis of a follow-up program in patients with breast cancer: a randomized prospective studyAmparo Oltra, A Santaballa, B Munárriz, et al.
Journal of Photochemistry and Photobiology. B, Biology|May 29, 2002
Reaction pathways and mechanisms of photodegradation of pesticidesH D Burrows, M Canle L, J A Santaballa, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|March 9, 2004
Diethyl 1-(4-fluorophenyl)-3-(2-furyl)-5-oxopyrrolidine-2,2-dicarboxylate and diethyl 1-(3,4-dichlorophenyl)-3-(2-furyl)-5-oxopyrrolidine-2,2-dicarboxylateJayanta Kumar Ray, Pranab Haldar, M Canle L, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
ESHAP is an active regimen for relapsing Hodgkin's diseaseJ Aparicio, A Segura, S Garcerá, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
1-(3-Chloro-4-fluoro-phen-yl)-5-(2-diazo-acet-yl)-4-phenyl-pyrrolidin-2-oneJayanta Kumar Ray, Pranab Haldar, M Canle L, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
Diethyl 1-(4-methyl-phen-yl)-3-phenyl-5-oxopyrrolidine-2,2-dicarboxyl-ateJayanta Kumar Ray, Gopa Barman, M Canle L, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1992
Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistryD R Vera
Pageof 33